IBK Capital
VC Fund
Toronto, Canada
IBK Capital is an independent and privately owned investment banking firm which offers a full range of financial advisory services. Such services include private placements of equity and debt, going public by way of reverse take-over, merger, acquisition and divestiture advisory services, valuations, fairness opinions and take-over defenceplanning. The Firm’s corporate objective is to provide the highest quality independent financial advisory services to its clients.IBK Capital was founded by a group of experienced professionals who had previously worked for many years as investment bankers with Merrill Lynch Canada Inc. Since its inception in February 1989, IBK Capital has established an enviable track record as an independent Canadian financial advisory firm, having played a role in transactions with a combined value of $5.6 billion. IBK Capital has successfully completed numerous financial advisory engagements including capital raising assignments for a large number of companies, globally. The Team is proud of its expertise and has a solid track record in the Canadian investment banking community.Companies serviced by IBK Capital are active in the MINING SECTOR (precious metals, base metals, precious gems, industrial minerals, coal and uranium), the RENEWABLE ENERGY SECTOR (solar, wind and bio fuels such as peat) and the TECHNOLOGY SECTOR (semiconductors, telecommunications, environmental sciences and animation).
- Total investments:
- 24
- Last investment:
- Lead investor:
- 4%
Last updated:
For AI agents: llms.txt
Industries IBK Capital invests in
Stages IBK Capital invests in
Countries IBK Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Seed
- $669k–$1.3M
- Series A
- $1.2M–$32M
- Series B
- $15M–$22M
Investment Focus
Industry
- Biotechnology 5 (21%)
- Health Care 4 (17%)
- Gaming 2 (8%)
- Rental 2 (8%)
- Travel 2 (8%)
Stage
- Series A 9 (38%)
- Series B 5 (21%)
- Seed 4 (17%)
- Funding Round 3 (13%)
- Series C 2 (8%)
Country
- South Korea 20 (83%)
- United Kingdom 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Michael White
President and Chief Executive Officer
|
President and Chief Executive Officer | Total investments: 0 | Find email | |
William F. White
Founder and Chairman
|
Founder and Chairman | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
HJ Wave
|
HJ Wave is a manufacturing comapny that designs and develops millimeter-wave RF band, including radar antennas for autonomous driving. | $23K / Dec 03, 2024 | |
|
HJ Wave
|
HJ Wave is a manufacturing comapny that designs and develops millimeter-wave RF band, including radar antennas for autonomous driving. | $31.8M / Series A / Dec 03, 2024 | |
SeaVantage
|
SeaVantage offers real-time info & AI-based predictions for stakeholders across the maritime logistics industry. | $1.2M / Dec 30, 2022 | |
|
SeaVantage
|
SeaVantage offers real-time info & AI-based predictions for stakeholders across the maritime logistics industry. | $1.2M / Series A / Dec 28, 2022 | |
|
SeaVantage
|
SeaVantage offers real-time info & AI-based predictions for stakeholders across the maritime logistics industry. | $1.3M / Seed / Dec 28, 2022 | |
MetaFines
|
MetaFines is a biopharma firm that creates anticancer medications with the goal of preventing the spread of cancer. By extending and reconfiguring the indications of off-label medications for terminal tumors, the company creates minimal anticancer pharmaceuticals. It also provides subcutaneous injections and therapies, allowing patients to fightcancer and enhance their standard of living with cancer metabolism.The company develops ow-toxic medicines for metabolic cancer. This low-toxic metabolic anti-cancer agent is distinguished by being created so that metabolic anti-cancer agents that limit cell growth but operate via various pathways can work in concert with one another. | $15.7M / Series B / Apr 28, 2022 | |
GGQ
|
GGQ platform helps gamers with in-depth personalization and reports to maximize potential. | $9M / Series A / Apr 13, 2022 | |
Ronfic
|
Ronfic develops a smart fitness healthcare system. | $3.4M / Series A / Jan 18, 2022 | |
Mthera Pharma
|
Mthera Pharma is a biopharmaceutical research and development company. | Series B / Dec 24, 2021 | |
Hobbyful
|
Habipool operates as an online hobby class service. | $3.5M / Series A / Oct 27, 2021 | |
| See all 24 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does IBK Capital invest in?
IBK Capital invests primarily in Biotechnology, Health Care and Gaming startups, most often at Series A and Series B stage. Most of the 24 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is IBK Capital's check size?
IBK Capital typically joins rounds of $669k–$1.3M at Seed, $1.2M–$32M at Series A and $15M–$22M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds IBK Capital participates in.
How do I contact IBK Capital?
Public channels for IBK Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at IBK Capital?
The team at IBK Capital includes Michael White (President and Chief Executive Officer) and William F. White (Founder and Chairman). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
